MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Sex Is Not a Major Determinant of Pallidus Internus Deep Brain Stimulation Outcome in Dystonia

    R. Telese, L. Romito, N. Golfrè Andreasi, G. Zorzi, A. Elia, S. Rinaldo, G. Devigili, R. Cilia, G. Messina, V. Levi, A. Franzini, R. Eleopra (Milan, Italy)

    Objective: To investigate the role of sex as a biological variable in efficacy and safety of GPi DBS in adults with dystonia. Background: Sex- related…
  • 2023 International Congress

    Long-term follow up of Deep Brain Stimulation in Pantothenate Kinase-Associated Neurodegeneration Syndrome: two case reports

    D. Damas, I. Carvalho, S. Caldeira, P. Monteiro, R. Pereira, I. Cunha, F. Moreira (Coimbra, Portugal)

    Objective: To present the long-term outcomes of deep brain stimulation in two cases of Pantothenate kinase-associated neurodegeneration (PKAN) syndrome. Background: PKAN syndrome is an autosomal-recessive…
  • 2023 International Congress

    Left hemisphere theta coherence between cortex and STN increases during speech

    A. Nakhmani, R. Smith, V. Del Bene, M. Nelson, J. Olson, S. Brinkerhoff, Z. Irwin, J. Bentley, R. Knight, H. Walker (Birmingham, USA)

    Objective: This study contrasts coherence between motor cortex and subthalamic nucleus (STN) field potentials across deep brain stimulation (DBS) implant hemispheres in patients with Parkinson’s…
  • 2023 International Congress

    Is an integrated Parkinson’s Dementia Service the way forward?

    A. Rafeeq, C. Thomas, B. Mohamed, J. Adenwalla, S. Page, R. Lewis-Morton, S. Mahon, T. Williams (Cardiff, United Kingdom)

    Objective: To illustrate the role of a single team in managing all facets of Parkinson’s Background: The Cardiff and Vale Parkinson’s service is an integrated,…
  • 2023 International Congress

    Next-generation sequencing analysis of circulating microRNAs in multiple system atrophy

    MC. Kuo, SP. Lin, RM. Wu (Taipei, Taiwan)

    Objective: The discriminatory peripheral circulating small non-coding RNAs (sncRNAs) using next-generation sequencing (NGS) between patients of multiple system atrophy (MSA), Parkinson's disease (PD), and healthy controls…
  • 2023 International Congress

    Post-Covid parkinsonism: a systematic review of clinical presentations

    P. Polverino, S. Lalli, M. Lo Giudice, A. Albanese (Rozzano, Italy)

    Objective: We performed a critical appraisal of the COVID-19-related parkinsonism cases reported in the literature so far, providing a phenomenological and diagnostic framework based on…
  • 2023 International Congress

    The pivotal difference in gut microbiota between multiple system atrophy and Parkinson’s disease

    SY. Cheng, MC. Kuo, YF. Tseng (Taipei, Taiwan)

    Objective: The knowledge gap between microbiome dysbiosis and pathogenesis of multiple system atrophy (MSA) remains. Background: Mounting evidence has found significant alterations in the gut…
  • 2023 International Congress

    Preliminary Report on Neuromelanin-Sensitive MRI Signal change after Allogeneic Bone marrow-derived Mesenchymal Stem Cells therapy: Phase IIa double-blind, randomized controlled trial

    J. Suescun, M. Schiess, E. Rodarte, C. Adams, T. Ellmore (Houston, USA)

    Objective: To select the most effective number of repeat doses of mesenchymal stem cells (MSC) delivered intravenously to slow the progression of Parkinson’s disease (PD).…
  • 2023 International Congress

    Motor phenotype and disease burden among Parkinson’s disease patients of Addis Ababa, Ethiopia.

    B. Getahun, H. Demissie, H. Nuri, S. Gugssa (Dire Dawa, Ethiopia)

    Objective: This study aims to characterize the motor phenotype of Parkinson’s disease (PD), compare disease severity and to determine quality of life among the different…
  • 2023 International Congress

    Crushing valbenazine capsule contents for potential addition to soft foods or administration via G tube

    M. Hebert, A. Mar, R. Moore, A. Bristow, S. Siegert (San Diego, USA)

    Objective: To evaluate the suitability of mixing crushed contents from valbenazine capsules with soft foods/liquids or adding them to water for delivery through a gastrostomy…
  • « Previous Page
  • 1
  • …
  • 112
  • 113
  • 114
  • 115
  • 116
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley